BR0200536A - Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase - Google Patents
Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductaseInfo
- Publication number
- BR0200536A BR0200536A BR0200536-0A BR0200536A BR0200536A BR 0200536 A BR0200536 A BR 0200536A BR 0200536 A BR0200536 A BR 0200536A BR 0200536 A BR0200536 A BR 0200536A
- Authority
- BR
- Brazil
- Prior art keywords
- reductase inhibitors
- aldose reductase
- sulfonylpyridazinane
- compounds useful
- prodrug
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/18—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSTOS DE SULFONILPIRIDAZINANA úTEIS COMO INIBIDORES DE ALDOSE REDUCTASE". Esta invenção refere-se a novos compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase no tratamento ou prevenção de certas complicações derivadas da diabetes mellitus, composições farmacêuticas compreendendo o sulfonilpiridazinana, composições farmacêuticas compreendendo uma combinação da sulfonilpiridazinana com um segundo agente farmacêutico, métodos terapêuticos compreendendo a administração de compostos de sulfonilpiridazinana, métodos terapêuticos compreendendo a administração dos compostos de sulfonilpiridazinana em combinação com um segundo agente farmacêutico e compostos úteis como intermediários para a preparação dos compostos de sulfonilpiridazinana desta invenção.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27225401P | 2001-02-28 | 2001-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0200536A true BR0200536A (pt) | 2003-04-29 |
Family
ID=23039045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0200536-0A BR0200536A (pt) | 2001-02-28 | 2002-02-27 | Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase |
Country Status (9)
Country | Link |
---|---|
US (1) | US6730674B2 (pt) |
EP (1) | EP1236720B1 (pt) |
JP (1) | JP2003128657A (pt) |
AT (1) | ATE297902T1 (pt) |
BR (1) | BR0200536A (pt) |
CA (1) | CA2373395C (pt) |
DE (1) | DE60204611T2 (pt) |
ES (1) | ES2240657T3 (pt) |
MX (1) | MXPA02002252A (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU714980B2 (en) | 1996-07-24 | 2000-01-13 | Warner-Lambert Company Llc | Isobutylgaba and its derivatives for the treatment of pain |
HUP0303920A3 (en) * | 2001-04-30 | 2004-07-28 | Pfizer Prod Inc | Pharmaceutical compositions containing combinations of aldose reductase inhibitor pyridazinons and cyclooxygenase 2 inhibitors |
AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
KR20030061051A (ko) * | 2002-01-07 | 2003-07-18 | 대한민국 (경상대학교 총장) | 신규한 아렌(혹은 알케인)술폰일피리다진온 유도체, 이의제조방법 및 유기반응에서의 용도 |
JP4880591B2 (ja) | 2004-06-04 | 2012-02-22 | テバ ファーマシューティカル インダストリーズ リミティド | イルベサルタンを含む医薬組成物 |
DK1919878T3 (da) * | 2005-07-21 | 2010-10-25 | Hoffmann La Roche | Pyridazinonderivater som thyroidhormonreceptoragonister |
EP2116618A1 (en) | 2008-05-09 | 2009-11-11 | Agency for Science, Technology And Research | Diagnosis and treatment of Kawasaki disease |
GB0907601D0 (en) * | 2009-05-01 | 2009-06-10 | Equateq Ltd | Novel methods |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE574204A (fr) * | 1958-12-24 | 1959-06-24 | Henri Morren | Dérives de sulfonyl-pyridazine |
IE47592B1 (en) | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
US4939140A (en) | 1985-11-07 | 1990-07-03 | Pfizer Inc. | Heterocyclic oxophthalazinyl acetic acids |
US4996204A (en) | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
FR2647676A1 (fr) | 1989-06-05 | 1990-12-07 | Union Pharma Scient Appl | Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase |
CA2107104A1 (en) * | 1991-03-28 | 1992-09-29 | Banavara L. Mylari | Pyridazinone acetic acids as aldose reductase inhibitors |
TW438587B (en) | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
ES2231681T3 (es) * | 2001-03-30 | 2005-05-16 | Pfizer Products Inc. | Inhibidores de piridazinona de la aldosa reductasa. |
AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
-
2002
- 2002-02-20 AT AT02251173T patent/ATE297902T1/de not_active IP Right Cessation
- 2002-02-20 EP EP02251173A patent/EP1236720B1/en not_active Expired - Lifetime
- 2002-02-20 ES ES02251173T patent/ES2240657T3/es not_active Expired - Lifetime
- 2002-02-20 DE DE60204611T patent/DE60204611T2/de not_active Expired - Fee Related
- 2002-02-26 CA CA002373395A patent/CA2373395C/en not_active Expired - Fee Related
- 2002-02-26 US US10/085,609 patent/US6730674B2/en not_active Expired - Fee Related
- 2002-02-27 JP JP2002050684A patent/JP2003128657A/ja not_active Withdrawn
- 2002-02-27 BR BR0200536-0A patent/BR0200536A/pt not_active IP Right Cessation
- 2002-02-27 MX MXPA02002252A patent/MXPA02002252A/es unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA02002252A (es) | 2002-09-30 |
CA2373395A1 (en) | 2002-08-28 |
ATE297902T1 (de) | 2005-07-15 |
US20030004139A1 (en) | 2003-01-02 |
CA2373395C (en) | 2006-01-10 |
DE60204611D1 (de) | 2005-07-21 |
US6730674B2 (en) | 2004-05-04 |
JP2003128657A (ja) | 2003-05-08 |
EP1236720B1 (en) | 2005-06-15 |
ES2240657T3 (es) | 2005-10-16 |
EP1236720A1 (en) | 2002-09-04 |
DE60204611T2 (de) | 2006-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200309887B (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. | |
NO20062644L (no) | DPP-IV inhibitorer | |
WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
NO20035327D0 (no) | Biologisk aktive metylen-blått derivater | |
DK1487444T3 (da) | Anvendelse af pyridylamider som angiogeneseinhibitorer | |
CY1106958T1 (el) | Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα | |
PL1940786T3 (pl) | Pochodne bifenylowe i ich zastosowanie w leczeniu zapalenia wątroby typu C | |
EP1764092A3 (en) | Selecting compounds for treatment of Alzheimer's disease | |
WO2006047528A3 (en) | Pyrazolobenzamides and derivatives as factor xa inhibitors | |
WO2005021497A3 (en) | Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones | |
EP1371640A4 (en) | NEW A-LIPONIC ACID DERIVATIVE AND ITS USE | |
NO331012B1 (no) | N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
BR0200536A (pt) | Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase | |
MX2008001778A (es) | Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma. | |
IL190024A0 (en) | Stabilized protease composition | |
UA83266C2 (en) | Oxazole derivatives of tetracyclines | |
WO2006027345A3 (en) | Novel 3-thia-10-aza-phenanthrene derivatives | |
NO20053997D0 (no) | Oligosaccharidderivat | |
PT1072601E (pt) | Derivados de 4-arilpiperidina para o tratamento de prurido | |
ATE334977T1 (de) | Discodermolid-analoga und ihre pharmazeutische verwendung | |
BR0211207A (pt) | Derivados de 2-(aminometil)-tetrahidro-9-oxa-1,3-diaza-ciclopenta[ a]naftalenila com atividade antipsicótica | |
ZA200710662B (en) | 1-[2', 3'-dideoxy-3' C-(hydroxymethyl)-beta-d-erythropentofuranosyl] cytosine derivatives as HIV inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1980 DE 16/12/2008. |